U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 20:28:58 GMT 2025
Edited
by admin
on Wed Apr 02 20:28:58 GMT 2025
Protein Type BISPECIFIC ANTIBODY
Protein Sub Type BISPECIFIC T CELL ENGAGER|IGG1|KAPPA
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
8YNA3QG3DS
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Nesfrotamig
INN  
Official Name English
ABL-105
Preferred Name English
YH32367
Code English
H-gamma1 heavy chain anti-ERBB2 fused to a scFvlh anti-TNFRSF9 (1-719) [H-gamma1 heavy chain anti-ERBB2 humanized (1-450) [VH (Homo sapiens IGHV3-66*01 (81.6%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.13] (26-33.51-58.97-109)) (1-120)-Homo sapiens IGHG1*0
Common Name English
Immunoglobulin G1, bispecific, anti-(human/Macaca fascicularis epidermal growth factor receptor HER2) (human-Mus musculus monoclonal YH32367 ?1-chain) fusion protein with peptide linker ((GS)9) fusion protein with immunoglobulin anti-(human/Macaca fascic
Common Name English
HER2/4-1BB bispecific antibody, YH32367
Common Name English
nesfrotamig [INN]
Common Name English
ABL105
Code English
YH-32367
Code English
immunoglobulin (H-gamma1-scFvlh_L-kappa) dimer, anti-[Homo sapiens ERBB2 (receptor tyrosine-protein kinase erbB-2, epidermal growth factor receptor 2, EGFR2, HER2, HER-2, p185c-erbB2, NEU, CD340)] and anti-[Homo sapiens TNFRSF9 (TNF receptor superfamily
Common Name English
Code System Code Type Description
INN
13381
Created by admin on Wed Apr 02 20:28:58 GMT 2025 , Edited by admin on Wed Apr 02 20:28:58 GMT 2025
PRIMARY
CAS
2966936-23-0
Created by admin on Wed Apr 02 20:28:58 GMT 2025 , Edited by admin on Wed Apr 02 20:28:58 GMT 2025
PRIMARY
NCI_THESAURUS
C192011
Created by admin on Wed Apr 02 20:28:58 GMT 2025 , Edited by admin on Wed Apr 02 20:28:58 GMT 2025
PRIMARY
FDA UNII
8YNA3QG3DS
Created by admin on Wed Apr 02 20:28:58 GMT 2025 , Edited by admin on Wed Apr 02 20:28:58 GMT 2025
PRIMARY
From To
4_23 4_88
4_134 4_194
3_134 3_194
3_23 3_88
2_642 2_694
2_571 2_620
2_490 2_557
2_370 2_428
2_264 2_324
2_223 4_214
2_147 2_203
2_22 2_96
1_642 1_694
1_571 1_620
1_490 1_557
1_370 1_428
1_264 1_324
1_232 2_232
1_229 2_229
1_223 3_214
1_147 1_203
1_22 1_96
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_300
N 2_300
Related Record Type Details
TARGET -> ACTIVATOR
Activates T-cells targeted to Her-2
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL